Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C

Economic Evaluation of Different Organizational Models for the Management of Patients with Hepatitis C

BACKGROUND: Access to Directly Acting Antivirals (DAAs) for Hepatitis C Virus (HCV) treatment in Italy was initially restricted to severe patients. In 2017, AIFA expanded access to all patients, to achieve elimination by 2030. AIM: To investigate the impact of different hospitals’ organizational mod...

Full description

Bibliographic Details
Main Authors: Stefano Fagiuoli, Luisa Pasulo, Franco Maggiolo, Rosaria Spinella, Paolo Del Poggio, Roberto Boldizzoni, Mariella Di Marco, Alessandro Aronica, Chiara Benedetti, Paolo Correale, Chiara Garavaglia, Carlo Nicora
Format: Article
Language:English
Published: SEEd Medical Publishers 2019-01-01
Series:Farmeconomia: Health Economics and Therapeutic Pathways
Subjects:
hepatitis c
italy
models, organizational
antiviral agents
daa
hcv
hub & spoke
center of excellence
Online Access:https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1374

Internet

https://journals.seedmedicalpublishers.com/index.php/FE/article/view/1374

Similar Items